IS7660A - Nýjar bensóímídasólafleiður nytsamlegar sem andviðkomumiðlar - Google Patents

Nýjar bensóímídasólafleiður nytsamlegar sem andviðkomumiðlar

Info

Publication number
IS7660A
IS7660A IS7660A IS7660A IS7660A IS 7660 A IS7660 A IS 7660A IS 7660 A IS7660 A IS 7660A IS 7660 A IS7660 A IS 7660A IS 7660 A IS7660 A IS 7660A
Authority
IS
Iceland
Prior art keywords
antidepressants
useful
new
benzoimidazole derivatives
benzoimidazole
Prior art date
Application number
IS7660A
Other languages
English (en)
Other versions
IS2738B (is
Inventor
Charles Kath John
Peter Lyssikatos Joseph
Fay Wang Huifen
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS7660A publication Critical patent/IS7660A/is
Publication of IS2738B publication Critical patent/IS2738B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS7660A 2002-08-28 2005-01-20 Tæki til þess að hreinsa bræddan málm IS2738B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40652402P 2002-08-28 2002-08-28
US41704702P 2002-10-08 2002-10-08
PCT/IB2003/003634 WO2004020431A2 (en) 2002-08-28 2003-08-14 Novel benzoimidazole derivatives useful as antiproliferative agents

Publications (2)

Publication Number Publication Date
IS7660A true IS7660A (is) 2005-01-20
IS2738B IS2738B (is) 2011-06-15

Family

ID=31981411

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7660A IS2738B (is) 2002-08-28 2005-01-20 Tæki til þess að hreinsa bræddan málm

Country Status (41)

Country Link
US (1) US7071337B2 (is)
EP (1) EP1594858B1 (is)
JP (1) JP4551771B2 (is)
KR (2) KR20070086768A (is)
CN (1) CN1319966C (is)
AP (1) AP2005003237A0 (is)
AR (1) AR041055A1 (is)
AT (1) ATE445610T1 (is)
AU (1) AU2003250499B2 (is)
BR (1) BRPI0313942C1 (is)
CA (1) CA2495577C (is)
CR (1) CR7698A (is)
CU (1) CU23413B7 (is)
CY (1) CY1110580T1 (is)
DE (1) DE60329715D1 (is)
DK (1) DK1594858T3 (is)
DO (1) DOP2003000694A (is)
EA (1) EA008448B1 (is)
EC (1) ECSP055633A (is)
ES (1) ES2333219T3 (is)
GE (1) GEP20064005B (is)
HK (1) HK1078571A1 (is)
HN (1) HN2003000257A (is)
HR (1) HRP20050191B1 (is)
IL (1) IL166832A (is)
IS (1) IS2738B (is)
MA (1) MA27389A1 (is)
MX (1) MXPA05001256A (is)
MY (1) MY139357A (is)
NO (1) NO20051303L (is)
NZ (1) NZ538427A (is)
OA (1) OA12916A (is)
PA (1) PA8580301A1 (is)
PE (1) PE20050131A1 (is)
PL (1) PL377678A1 (is)
PT (1) PT1594858E (is)
RS (1) RS20050180A (is)
SI (1) SI1594858T1 (is)
TW (1) TW200407131A (is)
UY (1) UY27952A1 (is)
WO (1) WO2004020431A2 (is)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2315663T3 (es) * 2003-06-24 2009-04-01 Pfizer Products Incorporated Procedimiento para la preparacion de derivados de 1-((benzoimidazol-1-il)quinolin-8-il)piperidin-4-ilamina.
WO2005094830A1 (en) * 2004-03-30 2005-10-13 Pfizer Products Inc. Combinations of signal transduction inhibitors
GB0411421D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds
CA2582479C (en) * 2004-10-07 2011-07-12 Pfizer Products Inc. Benzoimidazole derivatives useful as antiproliferative agents
EP1877444A2 (en) 2005-04-26 2008-01-16 Pfizer, Inc. P-cadherin antibodies
EA201300320A1 (ru) 2005-09-07 2014-02-28 Эмджен Фримонт Инк. Моноклональные антитела человека к киназе-1, подобной рецептору активина
CA2651629A1 (en) 2006-05-09 2007-11-22 Pfizer Products Inc. Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
UA101611C2 (ru) 2007-04-03 2013-04-25 Аррей Байофарма Инк. СОЕДИНЕНИЯ ИМИДАЗО[1,2-а]ПИРИДИНА КАК ИНГИБИТОРЫ ТИРОЗИНКИНАЗЫ РЕЦЕПТОРОВ
NZ602791A (en) * 2008-05-21 2014-04-30 Incyte Corp Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
WO2012028243A1 (en) 2010-09-02 2012-03-08 Merck Patent Gmbh Pyrazolopyridinone derivatives as lpa receptor antagonists
GB201103578D0 (en) 2011-03-02 2011-04-13 Sabrepharm Ltd Dipyridinium derivatives
JP6407504B2 (ja) 2012-09-21 2018-10-17 アログ・ファーマシューティカルズ・インコーポレイテッドArog Pharmaceuticals,Inc. 恒常的に活性であるリン酸化型flt3キナーゼの阻害方法
US10835525B2 (en) 2012-09-26 2020-11-17 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
TWI599356B (zh) 2012-09-26 2017-09-21 安羅格製藥有限責任公司 抑制突變型c-kit的方法
US11642340B2 (en) 2012-09-26 2023-05-09 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
BR112015016282A2 (pt) 2013-01-07 2017-07-11 Arog Pharmaceuticals Inc crenolanibe para tratamento de distúrbios proliferativos de flt3 mutado
US10463658B2 (en) 2013-10-25 2019-11-05 Videra Pharmaceuticals, Llc Method of inhibiting FLT3 kinase
UA122062C2 (uk) * 2014-10-31 2020-09-10 Дженосаєнс Фарма Заміщені 2,4-діамінохіноліни як протиракові засоби
GB2543550A (en) 2015-10-21 2017-04-26 Hox Therapeutics Ltd Peptides
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
DK3452465T3 (da) 2016-05-04 2021-02-08 Genoscience Pharma Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
EP3359155A4 (en) 2016-11-02 2019-05-22 Arog Pharmaceuticals, Inc. CRENOLANIB FOR THE TREATMENT OF MUTATIONS ASSOCIATED WITH FLT3-MUTED PROLIFERATIVE DISEASES
CN107382984B (zh) * 2017-08-24 2020-07-10 扬州市三药制药有限公司 一种治疗白血病药物的制备方法
CN107382983B (zh) * 2017-08-24 2020-08-07 扬州市三药制药有限公司 一种治疗白血病药物的合成方法
CN110840893A (zh) 2018-12-13 2020-02-28 安罗格制药有限责任公司 含克莱拉尼的药物组合物及其用途
US11471451B2 (en) 2019-08-19 2022-10-18 Arog Pharmaceuticals, Inc. Uses of crenolanib
CN113024435B (zh) * 2019-12-09 2022-06-17 苏州恩华生物医药科技有限公司 连双环结构sigma-1受体抑制剂
EP4073102A4 (en) 2019-12-12 2024-05-08 Ting Therapeutics LLC COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS
WO2022019998A1 (en) * 2020-07-20 2022-01-27 Arog Pharmaceuticals, Inc. Crystal forms of crenolanib and methods of use thereof
CN116234549A (zh) * 2020-08-05 2023-06-06 总医院公司 盐诱导激酶抑制剂
US11524006B2 (en) 2020-09-17 2022-12-13 Arog Pharmaceuticals, Inc. Crenolanib for treating TRK kinase associated proliferative disorders
US11969420B2 (en) 2020-10-30 2024-04-30 Arog Pharmaceuticals, Inc. Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders
CN113683594B (zh) * 2021-09-07 2022-12-27 曲靖师范学院 一种喹啉-苯并咪唑盐类化合物及其合成方法和应用
JP2023063189A (ja) 2021-10-22 2023-05-09 アログ・ファーマシューティカルズ・インコーポレイテッド 以前の治療に対して再発性/不応性のflt3突然変異増殖性障害を治療するためのクレノラニブ
WO2023081923A1 (en) 2021-11-08 2023-05-11 Frequency Therapeutics, Inc. Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof
CN114409632B (zh) * 2022-02-22 2024-04-30 北京鲲达宇科技有限公司 2-取代氨基-3-苯并咪唑取代的喹啉衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607683D0 (en) 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US5990146A (en) 1997-08-20 1999-11-23 Warner-Lambert Company Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
EP1017682A4 (en) 1997-09-26 2000-11-08 Merck & Co Inc NEW ANGIOGENESIS INHIBITORS
UA75055C2 (uk) * 1999-11-30 2006-03-15 Пфайзер Продактс Інк. Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі
US6624189B2 (en) * 1999-11-30 2003-09-23 The Board Of Trustees Of The Leland Stanford Junior University Byrostatin analogues, synthetic methods and uses
JP2008002005A (ja) * 2006-06-21 2008-01-10 Shimada Shoji Kk 衣服用パッド

Also Published As

Publication number Publication date
BR0313942A (pt) 2005-07-12
ATE445610T1 (de) 2009-10-15
BRPI0313942B1 (pt) 2019-06-04
KR20050036984A (ko) 2005-04-20
HRP20050191A9 (hr) 2013-11-22
US7071337B2 (en) 2006-07-04
ES2333219T3 (es) 2010-02-18
CR7698A (es) 2007-11-23
RS20050180A (en) 2007-08-03
CN1319966C (zh) 2007-06-06
PE20050131A1 (es) 2005-03-21
HK1078571A1 (en) 2006-03-17
AP2005003237A0 (en) 2005-03-31
EP1594858B1 (en) 2009-10-14
BRPI0313942B8 (pt) 2020-08-04
PT1594858E (pt) 2009-12-14
ECSP055633A (es) 2005-04-18
MXPA05001256A (es) 2005-06-08
MA27389A1 (fr) 2005-06-01
DE60329715D1 (de) 2009-11-26
CA2495577A1 (en) 2004-03-11
DK1594858T3 (da) 2009-12-14
AU2003250499B2 (en) 2009-04-23
KR20070086768A (ko) 2007-08-27
HRP20050191A2 (en) 2005-10-31
IL166832A (en) 2011-03-31
BRPI0313942C1 (pt) 2021-05-25
JP2006501309A (ja) 2006-01-12
DOP2003000694A (es) 2004-02-29
OA12916A (en) 2006-10-13
JP4551771B2 (ja) 2010-09-29
CU23413B7 (es) 2009-09-08
SI1594858T1 (sl) 2010-01-29
TW200407131A (en) 2004-05-16
US20050124599A1 (en) 2005-06-09
UY27952A1 (es) 2004-03-31
NO20051303L (no) 2005-05-18
PA8580301A1 (es) 2005-05-24
CA2495577C (en) 2010-06-15
PL377678A1 (pl) 2006-02-06
IS2738B (is) 2011-06-15
EP1594858A2 (en) 2005-11-16
GEP20064005B (en) 2006-12-25
MY139357A (en) 2009-09-30
WO2004020431A3 (en) 2004-05-13
WO2004020431A2 (en) 2004-03-11
NZ538427A (en) 2007-04-27
EA200500174A1 (ru) 2005-08-25
CY1110580T1 (el) 2015-04-29
HN2003000257A (es) 2004-12-01
KR100816166B1 (ko) 2008-03-21
CN1678604A (zh) 2005-10-05
AR041055A1 (es) 2005-04-27
EA008448B1 (ru) 2007-06-29
AU2003250499A1 (en) 2004-03-19
HRP20050191B1 (hr) 2013-12-20

Similar Documents

Publication Publication Date Title
IS7660A (is) Nýjar bensóímídasólafleiður nytsamlegar sem andviðkomumiðlar
IS7667A (is) Nýjar bensimídazólafleiður
DE60304683D1 (de) Auftrennwerkzeug
ITMI20020148A0 (it) Nuovi corticosteroidi
DK1492934T3 (da) Dørenhed
SE0500656L (sv) Spridare
NO20044140D0 (no) New Composition
ITMI20021327A1 (it) Nuove ossialchilpiperazine
UA6462S (uk) Шпалери
UA6467S (uk) Шпалери
UA6017S (uk) Шпалери
UA6026S (uk) Шпалери
UA6449S (uk) Шпалери
UA6452S (uk) Шпалери
UA6459S (uk) Шпалери
UA6454S (uk) Шпалери
UA6451S (uk) Шпалери
UA6023S (uk) Шпалери
UA6025S (uk) Шпалери
UA6453S (uk) Шпалери
UA6460S (uk) Шпалери
UA6461S (uk) Шпалери
UA6457S (uk) Шпалери
UA6463S (uk) Шпалери
UA6464S (uk) Шпалери